(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

L2P RESEARCH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

L2P RESEARCH

ST13

US500000088984763

Class

42

Filing

88984763

Registration

6925449

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

12/13/2022

Trademark type

Word

Nice classes

42

Filing date

01/02/2020

Registration date

12/13/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/13/2022

Last transaction

12/13/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/10/2018

First use in commerce

08/10/2018

Drawing code

4

Owner type

16

Owner location

Annville, PA, US

Examiner

HILL, JAMES T

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Lab TO Pharmacy, LLC

Representatives

James F. Harrington Hoffmann & Baron, LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development in the pharmaceutical and biotechnology fields; Research and development of advanced learning technologies and teaching methods; Research and development of new products; Research and development of new products for others; Research and development of vaccines and medicines; Research and development services in connection with physics; Research and development services in the field of antibodies; Research in the area of semiconductor processing technology; Research in the field of chemistry; Research on the subject of pharmaceuticals; Agrochemical research services; Bacteriological research; Bacteriological consultation and research; Biochemical research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Consulting services in the field of hydrological research; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Genotyping services for research or analysis purposes; Industrial research in the field of Biotechnology; Industrial research in the field of Immunology; Integrated scientific research on vermin for greenhouses and harvest crops; Laboratory research services relating to pharmaceuticals; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of Oncology; Medical and scientific research in the field of Cancer; Medical and scientific research in the field of Nature Therapeutics; Pharmaceutical research and development; Pharmaceutical research services; Product research; Product research and development; Providing information in the field of plant genetics research resources; Providing medical research and scientific research information in the field of oncology via the Internet; Providing scientific research information in the field of Tumor Immunology; Providing scientific research information in the field of Pre clinical Research; Providing scientific research information in the field of Animal Research; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research consulting in the field of in vitro fertilization; Scientific research for medical purposes in the area of cancerous diseases; Scientific and technological research relating to patent mapping; Technical research in the field of pharmaceutical studies; Testinginspection or research of pharmaceuticalscosmetics or foodstuff; Zoological research and consultation

Publications

History of USPTO decisions and trademark events.

37 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/13/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/13/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/10/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/09/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/03/2022

DPCC

DIVISIONAL PROCESSING COMPLETE

11/03/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/25/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/01/2022

IUAF

USE AMENDMENT FILED

07/07/2022

DRRR

DIVISIONAL REQUEST RECEIVED

07/07/2022

EISU

TEAS STATEMENT OF USE RECEIVED

07/07/2022

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

07/07/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/08/2022

EX3G

SOU EXTENSION 3 GRANTED

01/06/2022

EXT3

SOU EXTENSION 3 FILED

01/06/2022

EEXT

SOU TEAS EXTENSION RECEIVED

01/06/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/09/2021

EX2G

SOU EXTENSION 2 GRANTED

07/07/2021

EXT2

SOU EXTENSION 2 FILED

07/07/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/07/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/08/2021

EX1G

SOU EXTENSION 1 GRANTED

01/06/2021

EXT1

SOU EXTENSION 1 FILED

01/06/2021

EEXT

SOU TEAS EXTENSION RECEIVED

01/06/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/07/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/12/2020

PUBO

PUBLISHED FOR OPPOSITION

05/12/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/22/2020

ALIE

ASSIGNED TO LIE

04/02/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/24/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

03/24/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/24/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

03/24/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/24/2020

DOCK

ASSIGNED TO EXAMINER

03/24/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/08/2020

NWAP

NEW APPLICATION ENTERED

01/06/2020

Continuous trademark protection

Get notified about every new filing that threatens L2P RESEARCH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.